# Bristol-Myers Squibb (BMY) P/B ratio: 6.6× today

URL: https://funkfolio.com/stock/BMY/pb-ratio

> Bristol-Myers Squibb (BMY) P/B ratio is 6.6× today, against 6.0× at the end of fiscal 2025. Its median over 17 fiscal year-ends is 5.0×.

---

## Bristol-Myers Squibb (BMY) P/B ratio

**P/B ratio today:** 6.6× as of Nov 19, 2026, 10:08 AM UTC

Bristol-Myers Squibb (BMY) trades at 6.6× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 6.0×. That is 15.2% lower than the 7.0× of fiscal 2024. Figures as of 19 Nov 2026, 10:08 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **P/B ratio today:** 6.6×
- **P/B ratio, fiscal 2025:** 6.0×
- **Change on fiscal 2024:** −15.2%
- **Highest on record:** 8.6× fiscal 2017
- **Lowest on record:** 2.1× fiscal 2019
- **Fiscal years on record:** 17 2009–2025

Figures as of 19 Nov 2026, 10:08 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

### Bristol-Myers Squibb P/B ratio, in more detail

Today's figure is 10.4% above the fiscal 2025 year-end.

Across the 17 fiscal year-ends on record (2009–2025), the highest was 8.6× in fiscal 2017 and the lowest 2.1× in fiscal 2019. Today's P/B ratio is higher than at 76% of the 17 fiscal year-ends on record; their median is 5.0×.

### P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

### Bristol-Myers Squibb P/B ratio, year by year

Bristol-Myers Squibb (BMY) P/B ratio by fiscal year

| Fiscal year | P/B ratio | Change | Year ended | Share price at year-end | Book value per share |
| --- | --- | --- | --- | --- | --- |
| Today | 6.6× | — | Nov 19, 2026 | $59.56 | — |
| 2025 | 6.0× | 15.2% down | Dec 31, 2025 | $53.94 | $9.06 |
| 2024 | 7.0× | 93.7% up | Dec 31, 2024 | $56.56 | $8.06 |
| 2023 | 3.6× | 27.1% down | Dec 31, 2023 | $51.31 | $14.16 |
| 2022 | 5.0× | 27.7% up | Dec 31, 2022 | $71.95 | $14.47 |
| 2021 | 3.9× | 5.2% up | Dec 31, 2021 | $62.35 | $16.01 |
| 2020 | 3.7× | 73.9% up | Dec 31, 2020 | $62.03 | $16.75 |
| 2019 | 2.1× | 64.9% down | Dec 31, 2019 | $64.19 | $30.14 |
| 2018 | 6.1× | 29.7% down | Dec 31, 2018 | $51.98 | $8.57 |
| 2017 | 8.6× | 42.1% up | Dec 31, 2017 | $61.28 | $7.11 |
| 2016 | 6.1× | 25.0% down | Dec 31, 2016 | $58.44 | $9.63 |
| 2015 | 8.1× | 22.0% up | Dec 31, 2015 | $68.79 | $8.50 |
| 2014 | 6.6× | 13.9% up | Dec 31, 2014 | $59.03 | $8.89 |
| 2013 | 5.8× | 44.4% up | Dec 31, 2013 | $53.15 | $9.12 |
| 2012 | 4.0× | 6.5% up | Dec 31, 2012 | $32.59 | $8.07 |
| 2011 | 3.8× | 30.3% up | Dec 31, 2011 | $35.24 | $9.29 |
| 2010 | 2.9× | 13.5% down | Dec 31, 2010 | $26.48 | $9.10 |
| 2009 | 3.4× | — | Dec 31, 2009 | $25.25 | $7.50 |
| 2008 | — | — | Dec 31, 2008 | $23.25 | — |
| 2007 | — | — | Dec 31, 2007 | $26.52 | — |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

### How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

### Bristol-Myers Squibb, figure by figure

- [Bristol-Myers Squibb market cap](https://funkfolio.com/stock/BMY/market-cap)
- [Bristol-Myers Squibb revenue](https://funkfolio.com/stock/BMY/revenue)
- [Bristol-Myers Squibb earnings](https://funkfolio.com/stock/BMY/earnings)
- [Bristol-Myers Squibb earnings per share (EPS)](https://funkfolio.com/stock/BMY/eps)
- [Bristol-Myers Squibb P/E ratio](https://funkfolio.com/stock/BMY/pe-ratio)
- [Bristol-Myers Squibb P/S ratio](https://funkfolio.com/stock/BMY/ps-ratio)
- [Bristol-Myers Squibb free cash flow](https://funkfolio.com/stock/BMY/free-cash-flow)
- [Bristol-Myers Squibb operating margin](https://funkfolio.com/stock/BMY/operating-margin)
- [Bristol-Myers Squibb dividend](https://funkfolio.com/stock/BMY/dividend)
- [Bristol-Myers Squibb shares outstanding](https://funkfolio.com/stock/BMY/shares-outstanding)
- [Bristol-Myers Squibb total debt](https://funkfolio.com/stock/BMY/total-debt)
- [Bristol-Myers Squibb cash on hand](https://funkfolio.com/stock/BMY/cash)
- [Bristol-Myers Squibb total assets](https://funkfolio.com/stock/BMY/total-assets)
- [Bristol-Myers Squibb total liabilities](https://funkfolio.com/stock/BMY/total-liabilities)
- [Bristol-Myers Squibb net assets (shareholders' equity)](https://funkfolio.com/stock/BMY/net-assets)
- [Bristol-Myers Squibb return on equity (ROE)](https://funkfolio.com/stock/BMY/roe)
- [Bristol-Myers Squibb return on invested capital (ROIC)](https://funkfolio.com/stock/BMY/roic)

[Bristol-Myers Squibb (BMY) overview: price, valuation and scorecard](https://funkfolio.com/stock/BMY) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Bristol-Myers Squibb P/B ratio: questions and answers

**What is Bristol-Myers Squibb's P/B ratio?**

Bristol-Myers Squibb (BMY) trades at 6.6× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 6.0×. That is 15.2% lower than the 7.0× of fiscal 2024.

**Is Bristol-Myers Squibb's P/B ratio high or low compared with its own history?**

Today's P/B ratio is higher than at 76% of the 17 fiscal year-ends on record; their median is 5.0×.

**What are the highest and lowest P/B ratio figures on record for Bristol-Myers Squibb?**

Across the 17 fiscal year-ends on record (2009–2025), the highest was 8.6× in fiscal 2017 and the lowest 2.1× in fiscal 2019.

**How is Bristol-Myers Squibb's P/B ratio calculated?**

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Bristol-Myers Squibb it is on record here for 17 fiscal years, 2009 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

### Learn: P/B ratio

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [P/E ratio explained: what a high or low figure means](https://funkfolio.com/learn/stocks/pe-ratio)

  The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- [Piotroski F-score: the nine tests and what they show](https://funkfolio.com/learn/stocks/piotroski-f-score)

  The Piotroski F-score is a 0–9 count of simple accounting tests a company passes: four on profitability, three on debt, liquidity and share issuance, two on operating efficiency. Joseph Piotroski's 2000 paper found that among cheap, high book-to-market stocks, high scorers went on to beat low scorers. It is a screen of financial health, not a valuation.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Bristol-Myers Squibb (BMY) P/B ratio”, data as of 19 November 2026. https://funkfolio.com/stock/BMY/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.
